Skip to content

Total Tubeless Percutaneous Nephrolithotomy Without a Ureteral Catheter

A Comparative Study of Retrograde Ureteral Catheter Insertion or Not in Total Tubeless Percutaneous Nephrolithotomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05578807
Enrollment
100
Registered
2022-10-13
Start date
2022-09-28
Completion date
2025-01-10
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Calculi, Nephrolithotomy, Percutaneous

Brief summary

Total tubeless Percutaneous nephrolithotomy (PCNL) is a modified surgical method of PCNL surgery, that is, there is no indwelling nephrostomy tube and double-J tube during PCNL surgery. Compared with traditional PCNL surgery, it has the advantages of reducing pain, shortening operation time and reducing operation cost. Since this procedure was first performed in 2004, several randomized clinical studies have verified the safety and efficacy of total tubeless PCNL. Conventional total tubeless PCNL surgery requires the patient to first undergo retrograde transurethral ureteroscopic insertion of the ureteral catheter in the lithotomy position, and then change the patient to the prone position. However, a large number of literature reports and the surgical experience of PCNL in the past 20 years tell the investigators that the reverse insertion of ureteral catheter can cause many recent surgical complications.The study planned to perform the operation in the prone position without reverse insertion of a ureteral catheter in the total tubular PCNL surgery.

Detailed description

The purpose of this single-center, single-blind, randomized trial was to investigate whether without retrograde insertion of a ureteral catheter is appropriate for total tubeless percutaneous nephrolithotomy. It is planned to start in October 2022 and is expected to end in October 2024. Based on inclusion and exclusion criteria, 100 subjects were expected to be recruited. In a parallel group design, subjects were randomly assigned to two groups: the experimental group received total tubeless PCNL without reverse insertion of a ureteral catheter , and the control group received conventional total tubeless PCNL. The primary end point of the study was the incidence of postoperative complications according to the modified Clavien-Dindo complication grading system. Secondary end points included Stone-free rate, operation time, length of hospital stay, and medical costs. Measurement data were expressed as mean ± standard deviation (X ± S), and Student's t-test was used for intergroup comparisons. The counting data were expressed as frequency and percentage, and the chi-squared or Fisher's exact probability test were used for intergroup comparisons. The rank-sum test was used for grade data. P\<0.05 was considered statistically significant.

Interventions

PROCEDUREwithout reverse ureteral catheter insertion

In contrast to conventional total tubeless percutaneous nephrolithotomy, there was no reverse insertion of a ureteral catheter by transurethral ureteroscopy when a patient is placed in lithotomy position, no change in position, and no repeated disinfection.

Sponsors

The First Affiliated Hospital of University of South China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with kidney stones who met the indications for PCNL surgery. * the maximum diameter of calculi was less than 35 mm. * the width of hydronephrosis effusion was less than 25mm.

Exclusion criteria

* patients with infectious calculi confirmed by preoperative CT examination and blood biochemical indexes. * Patients with severe cardiac and pulmonary insufficiency, coagulation dysfunction and other obvious surgical contraindications. * Patients with previous history of PCNL surgery on the affected side or nephrotomy. * Patients with indwelling double J tube or nephrostomy tube before operation. * Patients with renal trauma or congenital anomalies of urinary system.

Design outcomes

Primary

MeasureTime frameDescription
Rate of hydrothoraxDay 2 after the surgeryHydrothorax appeared on the surgical side.
Hematocrit change valueDay 2 before surgery、hour 3 after the surgeryThe change value of Hematocrit between preoperative and postoperative
Rate of renal subcapsular hematomaDay 2 after the surgeryThe proportion of postoperative renal subcapsular hematoma in all patients
Serum creatinine change valueDay 2 before surgery、Hour 3 after the surgeryThe change value of Serum creatinine between preoperative and postoperative
visual analog scale (VAS)pain scoreHour 2 after the surgery0: no pain; Less than 3 points: mild pain, tolerable; 4 points to 6 points: the patient's pain and affect sleep, still tolerable; 7-10: Patients have increasing pain, pain is unbearable, affect appetite, affect sleep.
Rate of feverFrom the day of surgery to the day of discharge, up to 2 weeks.Fever was defined as axillary temperature greater than 38.5 ° C.
White blood cell count change valueDay 2 before surgery、hour 3 after the surgeryThe change value of White blood cell count between preoperative and
Neutrophils granulocyte change valueDay 2 before surgery、hour 3 after the surgeryThe change value of Neutrophils granulocyte between preoperative and postoperative
Hemoglobin change valueDay 2 before surgery、hour 3 after the surgeryThe change value of Hemoglobin between preoperative and postoperative

Secondary

MeasureTime frameDescription
Operation timeDuring the procedureOperation time was defined as the time required from the surgeon's handwashing to the completion of surgical incision suture.
length of hospital stay2 weeks after surgeryLength of hospital stay indicated the number of days between the operation date and discharge date
Medical costs2 weeks after surgeryAll medical expenses incurred to treat stones.
Stone free rateDay 2 after the surgeryResidual stone less than 4mm in diameter was considered to have been cleared.

Countries

China

Contacts

Primary ContactMingyong Li, MD.
myli1123@126.com137-8648-4606

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026